HOME >> MEDICINE >> NEWS
NIAID announces leadership for newly restructured HIV/AIDS clinical trials networks

The National Institute of Allergy and Infectious Diseases (NIAID) today announced the clinical investigators and institutions that will lead NIAID's newly restructured HIV/AIDS clinical trials networks in the search for safe and effective treatments and prevention strategies, including HIV vaccines. NIAID, part of the National Institutes of Health (NIH), supports the world's largest portfolio of clinical HIV/AIDS research.

"The new network structure expands our clinical research capacity and strengthens our ability to take advantage of emerging scientific opportunities," says NIAID Director Anthony S. Fauci, M.D. "By creating a more integrated, collaborative and flexible structure, we will be better equipped to meet evolving global AIDS research priorities."

These leadership group awards represent the first step of the two-part restructuring process of the HIV/AIDS clinical trials networks. Awards for the Clinical Trials Units (CTUs), which will carry out the clinical research, are expected to be announced later this year.

Each leadership group will be led by a principal investigator and include a core operations group that will provide administrative and technical support; a statistical and data management center; and a network laboratory structure. The following principal investigators and institutions will lead the newly restructured HIV/AIDS networks:

  • AIDS Clinical Trials Group (ACTG)--Constance A. Benson, M.D., University of California, San Diego
  • HIV Prevention Trials Network (HPTN)--Sten Vermund, M.D., Ph.D., Vanderbilt University, Nashville
  • HIV Vaccine Trials Network (HVTN)--Lawrence Corey, M.D., The Fred Hutchinson Cancer Research Center, Seattle
  • International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT)--Jay Brooks Jackson, M.D., Johns Hopkins University School of Medicine, Baltimore
  • Interna
    '"/>


Contact: Kathy Stover
kstover@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
29-Jun-2006


Page: 1 2 3

Related medicine news :

1. NIAID releases MDR/XDR Tuberculosis research agenda
2. NIAID DNA vaccine for H5N1 avian influenza enters human trial
3. NIAID media availability: Examining genetic variability of malaria parasite offers insight
4. NIAID awards $4 million to develop anti-radiation treatments
5. Partnership between NIAID and Sequella yields promising new TB drug for clinical testing
6. NIAID study finds higher dose of flu vaccine improves immune response in the elderly
7. NIAID media availability: New study describes key protein from highly pathogenic H5N1 avian flu virus and how it might mutate
8. NIAID media availability: Understanding influenza infection
9. NIAID researchers show how promising TB drug works
10. NIAID awards $47 million to develop medical countermeasures against radiological, nuclear threats
11. NIAID launches first Phase II trial of a global HIV/AIDS vaccine

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/18/2019)... ... 18, 2019 , ... Swiss Pet company PerAnimal launches a new ... bond between human and animal while improving the overall wellness of pet companions. , ... decades of experience. They are made by hand from organic Swiss herbal condensate and ...
(Date:4/18/2019)... , ... April 18, 2019 , ... She went from ... pair of eyeglasses, said her mother, Cheryl Reilly. Those “goofy tests,” performed by ... Mikayla Reilly, then 12 years old, had such narrow range of visual awareness, she ...
(Date:4/17/2019)... Fla. (PRWEB) , ... April 17, 2019 , ... With ... headlines, scientists are working to curb the death toll by looking for an alternative ... Spring 2019 National Meeting & Exposition this week. , Naloxone (often known by the ...
(Date:4/17/2019)... , ... April 17, 2019 , ... ... sufferers, announced a new initiative this April to designate April 19th as World ... strong support for research & healthcare professionals in their pursuit to find treatments. ...
(Date:4/17/2019)... ... April 17, 2019 , ... ... in revolutionary diagnostic technologies. This episode is scheduled to air 3Q 2019 on ... Innovations will focus on Credo Biomedical Pte. Ltd. (Credo Biomedical), a molecular diagnostic ...
Breaking Medicine News(10 mins):
(Date:4/17/2019)... ... 17, 2019 , ... To better address opioid addiction related ... Health have launched a new program that takes a novel, holistic approach to ... Management Program brings together a range of alternative, non-opioid therapies and support services ...
(Date:4/17/2019)... , ... April 17, 2019 , ... The Job ... that will support investigation into the causes of and treatments for Job Syndrome. ... projects that will take place around the globe in three countries, and on three ...
(Date:4/17/2019)... ... April 17, 2019 , ... ... Clinical Trial Design Strategies to Expedite Development of Oncology Drugs and Biologics’ ... alike. , Through years of experience helping sponsors manage complex oncology trials, ...
Breaking Medicine Technology:
Cached News: